Patents by Inventor Jens Larsen

Jens Larsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12163768
    Abstract: The invention relates to a sports shooting target made of a biodegradable material, the target having a rotational axis (z) and attachment means (2, 4?, 4?, 10, 11, 15) for releasable attachment to a launching device, where the target is provided with trajectory stabilizing means that are configured to stabilize the trajectory of the target by gyro effect caused by rotation about said rotational axis (z) which stabilizing means further function as propelling means that cause forward movement of the target along its trajectory due to the rotation about said rotational axis (z), when the target is rotating, where said stabilizing means comprises a fan comprising fan blades (3?, 3?) that rotates in unison with the target, when the target rotates, such that the stabilizing means both provides said stabilizing gyro effect and forward propulsion (movement) of the target along a chosen trajectory.
    Type: Grant
    Filed: April 6, 2020
    Date of Patent: December 10, 2024
    Assignee: NORDIC SPORTING CLAYS APS
    Inventor: Jens Larsen
  • Publication number: 20240369330
    Abstract: The invention relates to a launching head for launching two or more sports shooting targets, where each target is of a generally disc-shaped configuration. The launching head is of a generally tubular configuration defined by a longitudinally extending rotational axis and includes an outer circumferential support surface portion formed to fit into and support the respective targets. The launching head is provided with a plurality of retaining claw members configured to be able to pivot in a plane containing the longitudinal axis and pivot an angle relative to a plane extending perpendicularly to the longitudinal axis. The invention also relates to a launching device applying the head of the invention and to a sports shooting target that can be used for the launching head of the invention.
    Type: Application
    Filed: June 30, 2022
    Publication date: November 7, 2024
    Inventor: Jens Larsen
  • Publication number: 20240361106
    Abstract: A launching device for launching a sports shooting target made of a biodegradable material includes a launching head configured such that a hub portion of the target can be positioned on the launching head. The launching head includes a plurality of pivotally mounted retaining, claw members that are configured to be able to pivot between a first state, in which the claw members retain the hub portion of the target to the launching head and a second state, in which the claw members release the hub portion of the target from the launching head, where the device is provided with a longitudinally displaceable shaft or rod that is functionally connected to the claw members such that a longitudinal displacement (B, D) of the shaft results in said pivotal movement of the claw members.
    Type: Application
    Filed: July 11, 2024
    Publication date: October 31, 2024
    Applicant: NORDIC SPORTING CLAYS APS
    Inventor: Jens LARSEN
  • Patent number: 11866445
    Abstract: The present invention relates to novel substituted dihydrothienopyrimidines with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
    Type: Grant
    Filed: May 16, 2022
    Date of Patent: January 9, 2024
    Assignee: UNION therapeutics A/S
    Inventor: Jens Larsen
  • Publication number: 20220362259
    Abstract: The present invention relates to novel substituted pyrazoloazepin-4-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
    Type: Application
    Filed: June 10, 2021
    Publication date: November 17, 2022
    Inventors: Xifu LIANG, Jens LARSEN, Simon Feldbaek NIELSEN, Peter ANDERSEN
  • Publication number: 20220281889
    Abstract: The present invention relates to novel substituted dihydrothienopyrimidines with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
    Type: Application
    Filed: May 16, 2022
    Publication date: September 8, 2022
    Inventor: Jens LARSEN
  • Patent number: 11365204
    Abstract: The present invention relates to novel substituted dihydrothienopyrimidines with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
    Type: Grant
    Filed: September 20, 2018
    Date of Patent: June 21, 2022
    Assignee: Union therapeutics A/S
    Inventor: Jens Larsen
  • Publication number: 20220178661
    Abstract: The invention relates to a sports shooting target made of a biodegradable material, the target having a rotational axis (z) and attachment means (2, 4?, 4?, 10, 11, 15) for releasable attachment to a launching device, where the target is provided with trajectory stabilizing means that are configured to stabilize the trajectory of the target by gyro effect caused by rotation about said rotational axis (z) which stabilizing means further function as propelling means that cause forward movement of the target along its trajectory due to the rotation about said rotational axis (z), when the target is rotating, where said stabilizing means comprises a fan comprising fan blades (3?, 3?) that rotates in unison with the target, when the target rotates, such that the stabilizing means both provides said stabilizing gyro effect and forward propulsion (movement) of the target along a chosen trajectory.
    Type: Application
    Filed: April 6, 2020
    Publication date: June 9, 2022
    Inventor: Jens Larsen
  • Patent number: 11299497
    Abstract: The present invention relates to novel substituted tetrahydropyran dihydrothienopyrimidines with phosphodiesterase inhibitory activity, and to their use in therapy, and to pharmaceutical compositions comprising the compounds and to methods of treating diseases with the compounds (I).
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: April 12, 2022
    Assignee: UNION therapeutics A/S
    Inventors: Jens Larsen, Simon Feldbaek Nielsen, Peter Andersen
  • Patent number: 11292799
    Abstract: The present invention relates to novel substituted azetidine dihydrothienopyrimidines with phosphodiesterase inhibitory activity, and to their use in therapy, and to pharmaceutical compositions comprising the compounds and to methods of treating diseases with the compounds (I).
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: April 5, 2022
    Assignee: UNION THERAPEUTICS A/S
    Inventors: Mark Andrews, Daniel Rodriguez Greve, Jens Larsen
  • Patent number: 11065257
    Abstract: The present invention relates to novel substituted pyrazoloazepin-4-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
    Type: Grant
    Filed: December 12, 2017
    Date of Patent: July 20, 2021
    Assignee: LEO Pharma A/S
    Inventors: Xifu Liang, Jens Larsen, Simon Feldbaek Nielsen, Peter Andersen
  • Publication number: 20210070769
    Abstract: The present invention relates to novel substituted azetidine dihydrothienopyrimidines with phosphodiesterase inhibitory activity, and to their use in therapy, and to pharmaceutical compositions comprising the compounds and to methods of treating diseases with the compounds (I).
    Type: Application
    Filed: December 14, 2018
    Publication date: March 11, 2021
    Inventors: Mark ANDREWS, Daniel Rodriguez GREVE, Jens LARSEN
  • Patent number: 10906915
    Abstract: The present invention relates to novel substituted pyrazoloazepin-4-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
    Type: Grant
    Filed: December 12, 2016
    Date of Patent: February 2, 2021
    Assignee: LEO Pharma A/S
    Inventors: Xifu Liang, Jens Larsen, Simon Feldbaek Nielsen, Peter Andersen
  • Publication number: 20200385400
    Abstract: The present invention relates to novel substituted tetrahydropyran dihydrothienopyrimidines with phosphodiesterase inhibitory activity, and to their use in therapy, and to pharmaceutical compositions comprising the compounds and to methods of treating diseases with the compounds (I).
    Type: Application
    Filed: December 14, 2018
    Publication date: December 10, 2020
    Inventors: Jens LARSEN, Simon Feldbaek NIELSEN, Peter ANDERSEN
  • Publication number: 20200323869
    Abstract: The present invention relates to novel substituted pyrazoloazepin-4-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
    Type: Application
    Filed: December 12, 2017
    Publication date: October 15, 2020
    Applicant: LEO Pharma A/S
    Inventors: Xifu LIANG, Jens LARSEN, Simon Feldbaek NIELSEN, Peter ANDERSEN
  • Patent number: 10793580
    Abstract: The present invention relates to novel pyrazoloazepin-8-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
    Type: Grant
    Filed: December 12, 2016
    Date of Patent: October 6, 2020
    Assignee: LEO Pharma A/S
    Inventors: Xifu Liang, Jens Larsen
  • Publication number: 20200239493
    Abstract: The present invention relates to novel substituted dihydrothienopyrimidines with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
    Type: Application
    Filed: September 20, 2018
    Publication date: July 30, 2020
    Inventor: Jens LARSEN
  • Patent number: 10703751
    Abstract: The present invention relates to a compound according to formula (I) or pharmaceutically acceptable salts, hydrates, or solvates thereof; wherein R1 is C1-alkyl, R2 is C1-alkyl, R3 is C2-alkyl, R4 is hydrogen, R5 is hydrogen. The invention relates further to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to said compounds for use in the treatment autoimmune diseases and to intermediates for the preparation of said compounds.
    Type: Grant
    Filed: January 10, 2018
    Date of Patent: July 7, 2020
    Assignee: Leo Pharma A/S
    Inventors: Jens Larsen, Mogens Larsen, Lars Kyhn Rasmussen, Andreas Ritzen, Tine Marianne Duus
  • Publication number: 20200010477
    Abstract: The present invention relates to novel substituted pyrazoloazepin-4-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
    Type: Application
    Filed: December 12, 2016
    Publication date: January 9, 2020
    Inventors: Xifu LIANG, Jens LARSEN, Simon Feldbaek NIELSEN, Peter ANDERSEN
  • Publication number: 20190367512
    Abstract: The present invention relates to a compound according to formula (I) or pharmaceutically acceptable salts, hydrates, or solvates thereof; wherein R1 is C1-alkyl, R2 is C1-alkyl, R3 is C2-alkyl, R4 is hydrogen, R5 is hydrogen. The invention relates further to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to said compounds for use in the treatment autoimmune diseases and to intermediates for the preparation of said compounds.
    Type: Application
    Filed: January 10, 2018
    Publication date: December 5, 2019
    Inventors: Jens LARSEN, Mogens LARSEN, Lars Kyhn RASMUSSEN, Andreas RITZEN, Tine Marianne DUUS